Biohacking has the potential to optimize current human limits, both in the realm of clinical care and in terms of biological enhancements.

From organ and limb replacement to simple apps that track sleep habits, biohacking is gaining momentum as a movement.

The Biohacking Summit, produced in partnership by Ogilvy and New Lab, aims to showcase the people and technologies currently at the forefront of this movement.

Speakers from  IBM Watson, Mount Sinai Health System, Johnson & Johnson, Doc.AI, FLO Living, and MERCY Nutraceuticals join New Lab and Ogilvy on stage for an exploration of biohacking’s impact on the future of health.